Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Renovo Biosciences

2001 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
1 INVESTORS
Description

Provider of a drug discovery platform designed to offer treatment for multiple sclerosis. The company's platform uncover novel neuroregenerative therapies, enabling healthcare providers to cure their patients.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Healthcare Technology Systems
Other Pharmaceuticals and Biotechnology
Primary Office
  • 10000 Cedar Avenue
  • Cleveland, OH 44106
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Renovo Biosciences’s full profile, request a free trial.

Renovo Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Renovo Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Notox Technologies Corporate Venture Capital Minority 000 0000 000000 0